Rationalizing 5000-fold differences in receptor-binding rate constants of four cytokines.
暂无分享,去创建一个
[1] T. Clackson,et al. A hot spot of binding energy in a hormone-receptor interface , 1995, Science.
[2] J. García-Ruíz,et al. Prolactin increases cytosolic free calcium concentration in hepatocytes of lactating rats. , 1991, Endocrinology.
[3] Huan‐Xiang Zhou,et al. Electrostatic rate enhancement and transient complex of protein–protein association , 2008, Proteins.
[4] A. Sali,et al. Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.
[5] S. Masuda,et al. The role of carbohydrate in recombinant human erythropoietin. , 1990, European journal of biochemistry.
[6] X. Z. Zhou. Calculation of translational friction and intrinsic viscosity. II. Application to globular proteins. , 1995, Biophysical journal.
[7] T. Clackson,et al. Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. , 1998, Journal of molecular biology.
[8] R C Wade,et al. Protein-protein association: investigation of factors influencing association rates by brownian dynamics simulations. , 2001, Journal of molecular biology.
[9] Huan‐Xiang Zhou,et al. Energy landscape and transition state of protein-protein association. , 2006, Biophysical journal.
[10] Huan-Xiang Zhou,et al. Prediction of salt and mutational effects on the association rate of U1A protein and U1 small nuclear RNA stem/loop II. , 2008, The journal of physical chemistry. B.
[11] Gideon Schreiber,et al. Fundamental Aspects of Protein—Protein Association Kinetics , 2009 .
[12] A. Elcock,et al. Absolute protein-protein association rate constants from flexible, coarse-grained Brownian dynamics simulations: the role of intermolecular hydrodynamic interactions in barnase-barstar association. , 2010, Biophysical journal.
[13] A. McCoy,et al. Electrostatic complementarity at protein/protein interfaces. , 1997, Journal of molecular biology.
[14] Huan-Xiang Zhou,et al. Rate theories for biologists , 2010, Quarterly Reviews of Biophysics.
[15] Huan‐Xiang Zhou,et al. Prediction of protein-protein association rates from a transition-state theory. , 2007, Structure.
[16] Anthony A Kossiakoff,et al. The high- and low-affinity receptor binding sites of growth hormone are allosterically coupled. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] I. Wilson,et al. Shared and Unique Determinants of the Erythropoietin (EPO) Receptor Are Important for Binding EPO and EPO Mimetic Peptide* , 1999, The Journal of Biological Chemistry.
[18] W. Sebald,et al. Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. , 1994, European journal of biochemistry.
[19] Huan-Xiang Zhou,et al. Dissection of the high rate constant for the binding of a ribotoxin to the ribosome , 2009, Proceedings of the National Academy of Sciences.
[20] J. M. Beals,et al. Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions. , 2002, Biochemistry.
[21] M. Dwyer,et al. Dissecting the binding energy epitope of a high-affinity variant of human growth hormone: cooperative and additive effects from combining mutations from independently selected phage display mutagenesis libraries. , 2004, Biochemistry.
[22] J. Wells,et al. Structural and mutational analysis of affinity-inert contact residues at the growth hormone-receptor interface. , 1996, Biochemistry.
[23] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .
[24] Robert M. Stroud,et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation , 1998, Nature.
[25] D. Goeddel,et al. Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.
[26] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules J. Am. Chem. Soc. 1995, 117, 5179−5197 , 1996 .
[27] G Schreiber,et al. Electrostatically optimized Ras-binding Ral guanine dissociation stimulator mutants increase the rate of association by stabilizing the encounter complex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] Y. Wang,et al. A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor α chain , 1997 .
[29] J W Fisher,et al. Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. , 1988, The Journal of biological chemistry.
[30] S. Wenzel,et al. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies , 2007, The Lancet.
[31] P. Johnston,et al. EPO's Alter Ego: Erythropoietin Has Multiple Actions , 2002, Stem cells.
[32] S. Frank. Receptor dimerization in GH and erythropoietin action--it takes two to tango, but how? , 2002, Endocrinology.
[33] Y. Wang,et al. The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain. , 1998, European Journal of Biochemistry.
[34] J. Nerup,et al. Letter: Yersinia enterocolitica infection and thyroid disorders. , 1974, Lancet.
[35] A. Wickrema,et al. Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. , 1992, Blood.
[36] R. Baxter. Measurement of growth hormone and prolactin receptor turnover in rat liver. , 1985, Endocrinology.
[37] J A McCammon,et al. Computer simulation of protein-protein association kinetics: acetylcholinesterase-fasciculin. , 1999, Journal of molecular biology.
[38] P. Reinemer,et al. Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface , 1999, Cell.
[39] Gideon Schreiber,et al. Rational design of faster associating and tighter binding protein complexes , 2000, Nature Structural Biology.
[40] S. Frank. Minireview: Receptor Dimerization in GH and Erythropoietin Action-It Takes Two to Tango, But How? , 2002, Endocrinology.
[41] R C Wade,et al. Simulation of the diffusional association of barnase and barstar. , 1997, Biophysical journal.
[42] R. Puri,et al. Transcriptional up-regulation of interleukin 4 receptors by human immunodeficiency virus type 1 tat gene. , 1996, AIDS research and human retroviruses.
[43] S. Holgate,et al. IL-4 Receptor α Is an Important Modulator of IL-4 and IL-13 Receptor Binding: Implications for the Development of Therapeutic Targets1 , 2006, The Journal of Immunology.
[44] T. Arakawa,et al. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. , 1996, Biochemistry.
[45] M. Ultsch,et al. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.
[46] P. J. Randle,et al. Immunoassay of growth hormone in human serum. , 1961, Proceedings of the Royal Society of Medicine.
[47] Patrick England,et al. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone. , 2010, Journal of molecular biology.
[48] W. Sebald,et al. The interleukin‐4 site‐2 epitope determining binding of the common receptor γ chain , 1998 .
[49] A. Bondi. van der Waals Volumes and Radii , 1964 .
[50] Nathan A. Baker,et al. Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[51] P. Reinemer,et al. INTERLEUKIN-4 / RECEPTOR ALPHA CHAIN COMPLEX , 2000 .